250 related articles for article (PubMed ID: 23194144)
1. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
Debono M; Ross RJ
Clin Endocrinol (Oxf); 2013 May; 78(5):659-64. PubMed ID: 23194144
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies for hydrocortisone replacement.
Debono M; Price JN; Ross RJ
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
[TBL] [Abstract][Full Text] [Related]
3. Doses and steroids to be used in primary and central hypoadrenalism.
Debono M; Ross RJ
Ann Endocrinol (Paris); 2007 Sep; 68(4):265-7. PubMed ID: 17651687
[TBL] [Abstract][Full Text] [Related]
4. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
5. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
6. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
7. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers.
Newell-Price J; Whiteman M; Rostami-Hodjegan A; Darzy K; Shalet S; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2008 Jan; 68(1):130-5. PubMed ID: 17803699
[TBL] [Abstract][Full Text] [Related]
8. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
Lennernäs H; Skrtic S; Johannsson G
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
[TBL] [Abstract][Full Text] [Related]
9. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
[TBL] [Abstract][Full Text] [Related]
10. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
Debono M; Ross RJ; Newell-Price J
Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
[TBL] [Abstract][Full Text] [Related]
11. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
12. Optimal glucocorticoid therapy.
Debono M; Ross RJ
Endocr Dev; 2011; 20():173-180. PubMed ID: 21164270
[TBL] [Abstract][Full Text] [Related]
13. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy.
Chan S; Debono M
Ther Adv Endocrinol Metab; 2010 Jun; 1(3):129-38. PubMed ID: 23148157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
[TBL] [Abstract][Full Text] [Related]
16. [Modified-release hydrocortisone for glucocorticoid deficiency].
Nowotny H; Reisch N
Internist (Berl); 2020 Jun; 61(6):565-572. PubMed ID: 32394073
[TBL] [Abstract][Full Text] [Related]
17. Cortisol Circadian Rhythm and Insulin Resistance in Muscle: Effect of Dosing and Timing of Hydrocortisone Exposure on Insulin Sensitivity in Synchronized Muscle Cells.
Negri M; Pivonello C; Simeoli C; Di Gennaro G; Venneri MA; Sciarra F; Ferrigno R; de Angelis C; Sbardella E; De Martino MC; Colao A; Isidori AM; Pivonello R
Neuroendocrinology; 2021; 111(10):1005-1028. PubMed ID: 33130679
[TBL] [Abstract][Full Text] [Related]
18. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
[TBL] [Abstract][Full Text] [Related]
19. Is physiological glucocorticoid replacement important in children?
Porter J; Blair J; Ross RJ
Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
[TBL] [Abstract][Full Text] [Related]
20. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.
Whitaker M; Debono M; Huatan H; Merke D; Arlt W; Ross RJ
Clin Endocrinol (Oxf); 2014 Apr; 80(4):554-561. PubMed ID: 23980724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
